MedTrace Logo

Prophylactic Antibiotics in Prevention of Spontaneous Bacterial Peritonitis in Compensated Liver Cirrhosis

NCT04711122 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-10-28

No results posted yet for this study

Summary

timely short-term antibiotic prophylaxis is an essential step in the management of these patients . Prophylaxis must be instituted as early as variceal hemorrhage is suspected, and timely administration has been associated with a reduced re-bleeding rate and lower mortality .

More recently, the American Association for the Study of Liver Diseases (AASLD), the Department of Veterans Affairs (VA), and the American Society for Gastrointestinal Endoscopy (ASGE) recommended antibiotic prophylaxis in all cirrhotic patients with UGIB, regardless of its source (i.e. variceal or non-variceal) or the presence of ascites.

Conditions

Interventions

DRUG

Third generation cephalosporin antibiotics

Assessment of antibiotic effect

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nariman Gamal, MD · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-02-28
Completion
2023-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04711122 on ClinicalTrials.gov